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ABSTRACT
Gastric adenocarcinoma is a common neoplasia and is responsible for up to 30% of the overall deaths due to cancer. 
Advanced disease is mostly characterized by peritoneum, liver, and lung involvement. The spread of the disease to the bone 
is rare, and bone marrow dissemination is even rarer. In this setting, leukoerythroblastosis may be the initial manifestation of 
the disease. The authors report the case of a 64-year-old Caucasian man who sought medical care complaining of back pain, 
weakness, and weight loss. The physical examination revealed pallor, and the laboratory work-up depicted severe anemia 
and thrombocytopenia; the peripheral blood smear was consistent with leukoerythroblastosis. The ongoing investigation 
through a bone marrow biopsy showed massive involvement of the bone marrow by a signet ring cell adenocarcinoma. 
During hospitalization, the patient presented melena, and an upper digestive endoscopy depicted an ulcerated and 
infiltrative lesion in the cardia, upon which the histological examination revealed a signet ring cell adenocarcinoma. This case 
highlights the bone marrow invasion represented by bicytopenia and leukoerythroblastosis as the initial manifestation of 
this histological type of gastric cancer. Although treatment attempts were made with chemotherapy and radiotherapy, 
the patient died early on, showing the aggressive behavior of this form of tumoral presentation. 
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INTRODUCTION
Gastric cancer is the fifth most common neoplasia 
worldwide after cancer of the lung, colon, breast, 
and prostate. It is also the third most common 
cause of death due to cancer irrespective of gender, 
and in 2012 it was responsible for 723,000 deaths 
worldwide.1
Adenocarcinoma is the histological type in 90% 
of cases of gastric cancer, and the metastases most 
commonly occur in the peritoneum, liver, and lung. 
The bone marrow is rarely involved as the metastatic site 
of a gastric carcinoma, and only scant reports show this 
involvement as the first presentation of the neoplasm.2-4
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We report the case of a patient with a medical 
history of weight loss and bicytopenia (anemia and 
thrombocytopenia). No gastrointestinal symptoms 
were present. The diagnostic work-up revealed the 
presence of diffuse infiltration of the bone marrow by 
signet ring cells of gastric neoplasia origin.
CASE REPORT
A 64-year-o ld man sought medica l  care 
complaining of weakness, a weight loss of 10 kg, 
and back pain for the last 2 months that had worsened 
during the last 2 weeks. His medical history comprised 
hypertension and type 2 diabetes mellitus, which 
was regularly controlled with hydrochlorothiazide, 
losartan, and metformin. He smoked 80 packs/year 
of tobacco. He denied abdominal pain, nausea, 
vomiting, gastrointestinal bleeding, or intestinal 
habit changes. The initial physical examination 
showed a well-looking patient, though markedly 
emaciated. His weight was 68.3 kg, height 1.79 m 
(body mass index was 23.6), pulse 104 beats/min, 
and blood pressure 102/64 mmHg. No peripheral 
lymphadenomegaly was palpable. A mild systolic 
cardiac murmur was audible in the aortic area, and the 
abdomen was plain, flaccid, and free of ascites and 
visceromegaly. The remaining examination was normal. 
The laboratory tests showed bicytopenia represented 
by erythrocytes of 1,300,000/mm3 (reference range 
[RR]: 4,500,000-5,900,000/mm3), hemoglobin of 
3.9 g/dL (RR: 12.3-15.3 g/dL), hematocrit of 13.3% 
(RR: 36.0-45.0%), mean corpuscular volume of 
102.3 fL (RR: 80-100 fL), red cell distribution width of 
23.2% (RR: <14.9%) and reticulocytes of 78,000/mm3 
(RR: 16,400-95,000/mm3). The peripheral blood smear 
revealed the presence of 18% of orthochromatic 
erythroblasts per 100 leukocytes. The platelet count 
was initially 80,000/mm3, then 18,000/mm3 in a 
second measurement (RR: 150,000-400,000/mm3). 
Leukocytes of 14,100/mm3 (RR: 4,500-11,000/mm3) 
showed a marked shift to the left (neutrophils of 82%, 
promyelocytes 1%, myelocytes 2%, metamyelocytes 
3%, bands 5%, segmented 71%, lymphocytes 
15%, and monocytes 3%). Lactic dehydrogenase 
determination was 809 U/L (RR: <250 U/L). Renal 
function tests, electrolytes, liver enzymes, bilirubins, 
clotting tests, vitamin B12, and folic acid determinations 
were normal. Even though blood transfusions were 
carried out, the hemoglobin level returned to a very low 
titer over the following 2 days. Therefore, the patient 
was hospitalized with the working diagnoses of occult 
bleeding, myelodysplastic syndrome, or hemolysis.
The abdominal computed tomography (CT) 
showed lymphadenomegaly in the periaortic, 
interaortocaval portocaval, and in the lesser gastric 
curvature topographies.
Because of the hematological features, which 
were consistent with leukoerythroblastosis, a bone 
marrow biopsy was performed. After a suspicious 
episode of melena, an upper digestive endoscopy was 
undertaken, which revealed a protruding infiltrative 
and ulcerated lesion located in the cardia extending to 
the distal third of the esophagus. The gastric chamber 
was full of clots due to diffuse tumoral bleeding that 
hampered the evaluation of the tumor size (Figure 1). 
Biopsies were performed, followed by adrenalin and 
ethamolin infiltration in an attempt to control the 
bleeding sites. The histological report of the gastric 
biopsies revealed signet ring cell adenocarcinoma 
with mucinous areas (Figure 2). The bone marrow 
was so extensively infiltrated by the neoplasia that 
the hematopoietic elements were scarcely represented 
(1% of the sample). The immunohistochemical profile 
of the bone marrow biopsy revealed positivity for CK7, 
CK20, and CDX-2, and negativity for TTF-1 and PSA, 
which was consistent with the gastrointestinal primary 
site of the neoplastic cells (Figure 3).
Figure 1. Upper digestive endoscopy showing a 
protruding ulcerated, infiltrative gastric lesion located in 
the cardia that presents active bleeding.
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The t reatment  cons i s ted on hemostat i c 
radiotherapy and chemotherapy for metastatic gastric 
cancer. Modified FLOX (oxaliplatin, 5-fluorouracil, 
and leucovorin) was administered. The outcome was 
unfavorable and the patient died on the 15th day of 
the first chemotherapy cycle.
DISCUSSION
The gastric cancer is a frequent and aggressive 
entity. In 2016 in Brazil, the National Institute of 
Cancer (INCA) estimated the occurrence of 12,920 new 
cases of gastric cancer in men and 7,600 in women, 
which represents an estimated risk of 13.04 new 
cases in 100,000 men and 7.37 in 100,000 women.5 
Although the incidence of gastric cancer has decreased 
worldwide,1,5 the mortality related to the entity remains 
high. The 5-year survival rate in developing countries 
is 20%; while it is upto 30% in developed countries. 
In Brazil, unfortunately, 85% of the diagnoses of 
gastric cancer are made in advanced stages.6
The metastases of gastric carcinoma usually 
occur in the liver, peritoneum, and lymph nodes, and 
less frequently in the ovary, central nervous system, 
bone, lung, and soft tissue. Bone metastases are very 
uncommon in the advanced stages of gastric cancer. 
Figure 2. Photomicrography of the gastric biopsy. A - Poorly cohesive atypical cells with cytoplasm vacuoles (signet 
ring cells) (arrow) in a background of mucin and inflammatory cells (asterisk) (H&E, 400X); B - Pools of mucin (blue) 
in the background of tumor cells (PAS/Alcian blue stain, 200X).
Figure 3. Photomicrography of the bone marrow biopsy. A - Diffuse infiltration by adenocarcinoma with mucinous 
background (H&E, 200X) and signet ring cells (inset, H&E, 400X); B - Immunohistochemistry for CDX2 showing 
positive nuclear brown staining in bone marrow signet ring cells (arrow) (400X).
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Autopsy studies of patients with gastric carcinoma 
showed bone metastases in 10-15.9% of the cases,7-9 
while in patients submitted to theoretically curative 
resection, this rate decreases to 1.2-1.8%.10-12
The neoplastic infiltration of the bone marrow is 
extremely rare, and occurs in a small percentage of 
bone metastasis.13 Kim et al.14 reported the prevalence 
of 0.024% of the bone marrow infiltration confirmed 
by biopsy studies. Kwon et al.15 studied 26 patients 
with advanced gastric cancer with bone marrow 
involvement showing a concomitance of bone, 
pulmonary, and hepatic metastasis in 57%, 11%, and 
3.8%, respectively. The most frequent solid tumors 
that present diffuse bone marrow infiltration in adults 
are represented by the tumors of the prostate, breast, 
lung, thyroid, and stomach.16,17
The bone marrow is a heterogeneous tissue 
composed of ( i )  cel ls of hematopoietic origin 
(hematopoietic stem cell, osteoclasts, macrophages, 
and others) ;  ( i i )  cel ls  of mesenchymal or igin 
(mesenchymal stem cells, osteoblasts, adipocytes, 
and others); (iii) endothelial cells; and (iv) neural cells. 
These cells interact with each other determining 
a microenvironment that fosters hematopoiesis 
and bone remodeling. Once within the circulatory 
system, the neoplastic cells may invade the bone 
marrow and actively act in this microenvironment 
resulting in the development of metastatic neoplasia. 
The tumor growth is stimulated both by the activation 
of osteoclasts and by the release of growth factors 
within the bone marrow, and is inhibited by osseous 
formation and decreased osteoclastogenesis.13,18 
It seems that the tumor gastric cells induce the 
differentiation and activation of the osteoclasts by 
the production of cytokines and via the RANK/RANKL 
system.19 The poorly differentiated adenocarcinoma 
and the signet ring cell carcinoma are the histological 
types of gastric carcinoma mostly associated with bone 
marrow diffuse infiltration. These histological types 
present low adhesion molecules expression,20,21 thus 
partially explaining the diffuse infiltration. The precise 
mechanism involved in the bone metastasis still has 
not been fully explained. The clinical features of the 
bone metastases would result in the interaction of the 
neoplastic cells and the cells of the bone marrow. The 
gastric cancer’s bone metastases are usually multiple, 
nodular, and of lytic origin. The pain is the most 
frequent symptom.22
The disseminated carcinomatosis of the bone 
marrow, in turn, is characterized by the diffuse 
infiltration of the bone marrow tissue followed by an 
explosive proliferation of the neoplastic cells, which 
will be responsible for the hematologic complications.13
Previous studies3,13,19 on patients with gastric 
cancer and bone marrow infiltration have shown 
some particular traits: the patients are younger, there 
is an increased determination of alkaline phosphatase 
and lactate dehydrogenase, there is bone metastasis 
present, and a low incidence of hypercalcemia. These 
traits are associated with an aggressive histological 
pattern (signet ring cells or poorly differentiated 
carcinoma) when compared with gastric cancer 
without bone marrow involvement. The clinical 
outcome of these cases worsens very quickly due 
to the hematopoietic suppression and hastened 
tumoral cells proliferation. Intravascular disseminated 
coagulation, microangiopathic hemolytic anemia, 
anemia, thrombocytopenia, leukoerythroblastic 
reaction, and thrombotic and hemorrhagic events 
represent the dreadful complications in this group of 
patients.
Our patient presented weight loss and back pain; 
the bicytopenia without reticulocytosis, the increased 
DHL, and the leukoerythroblastosis consistent with 
bone marrow infiltration were all confirmed on the 
bone marrow biopsy.
The leukoerythroblastosis refers to the presence 
of neutrophilia with a marked shift to the left and to 
nucleated red blood cells in the peripheral blood smear 
in a patient without a primary hematological disease.23 
In case of replacement of the bone marrow tissue by 
neoplasia, granuloma, or fibrosis, the remaining stem 
cells migrate to the liver and spleen, resulting in the 
extramedullary hematopoiesis. Since the stroma of 
these extramedullary sites is not that efficient, the 
hematopoietic cells are prematurely delivered to the 
circulation. In this case, the reticulocytes count is of 
limited value since the nucleated red blood cells may 
mature in the peripheral blood as the reticulocytes may 
be disorderly released from the extramedullary sites.
The refractory anemia of our patient was assumed 
as a result of the impaired hematopoiesis (bone 
marrow infiltration) and the continuous bleeding 
by the neoplastic gastric lesion. The intravascular 
disseminated coagulation, a frequent complication 
of the diffuse bone marrow carcinomatosis, was not 
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characterized in our patient. The acute onset and 
continuous back pain was a major complaint, which 
was not diagnosed as being of neoplastic origin by 
the CT scan images. However, as we did not measure 
the alkaline phosphatase nor do a bone scintigraphic 
study, we could not rule out other bone metastasis in 
this case.
The survival time of patients with bone marrow 
disseminated carcinomatosis associated with gastric 
cancer is generally less than 3 months.5,14,22 Even 
with the advances in chemotherapeutic regimens, 
the prognosis remains poor and is never longer than 
1 year. Kwon et al.15 published a series with 16 patients 
receiving palliative chemotherapy and 10 patients 
receiving only palliative care. The mean survival time 
was 121 days for the palliative chemotherapy group, 
and 11 days for the palliative care group (p < 0.001).
Our patient was treated with hemostatic 
radiotherapy and chemotherapy for metastatic gastric 
cancer with modified FLOX (oxaliplatin, 5-fluorouracil 
and leucovorin)24 and died on the 15th day of the first 
chemotherapy cycle.
This case highlights bone marrow neoplastic 
invasion as a very unusual first presentation of signet 
ring cell gastric carcinoma. Moreover, in patients with 
back pain and/or an association with hemorrhagic 
symptoms, the presence of leukoerythroblastosis and 
an increase in lactic dehydrogenase should raise the 
suspicion of the massive involvement of bone marrow.
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